ArticleProceedings of the National Academy of Sciences of the United States of America2023

A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis.

Ji Hyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.